Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Patient Protection and Affordable Care Act
 More »

  • Pharma Builds Bridges with Advocacy Groups
    with patients to achieve the cost and time savings needed to bring new drugs to market in the brave new world wrought by the Patient Protection and Affordable Care Act (PPACA). ...
    5-7-2013
  • AMA Enters Diagnostic Fray
    already undergoing structural change under "Obamacare" or the Patient Protection and Affordable Care Act of 2010. Doctors would be better informed about the full range of ...
    3-1-2013
  • Biggest Biotech Trends of 2012
    issued its long-awaited draft guidance February 9 on the development and approval of biosimilar drugs, required under President Obama's Patient Protection and Affordable Care Act. ...
    1-15-2013
  • 7 Biotech Trends for the Coming Year
    FDA Should Finalize Draft Guidance With President Obama's Patient Protection and Affordable Care Act withstanding Supreme Court review last year (albeit by a single vote), ...
    1-3-2013
  • Biggest Biotech Trends of 2012
    its long-awaited draft guidance February 9 on the development and approval of biosimilar drugs, required under President Barack Obama's Patient Protection and Affordable Care Act. ...
    12-26-2012
  • One Small Step, No Giant Leap for Privacy
    sequencing in clinical care, hoping to strike the right ... and Accountability Act; the latter, by the federal ... balance researcher and patient interests yet protect ...
    10-17-2012
  • Biotech and the U.S. Government
    That said, the biosimilars provision of HR 3590, The Patient Protection and Affordable Care Act, however, is likely to stand, either as a provision of healthcare insurance reform ...
    8-21-2012
  • R&D Changes Foreseen After Supreme Court Obamacare Decision
    from government and private insurance programs under the Patient Protection and Affordable Care Act. "We have to develop drugs that are very highly and clear ...
    7-3-2012
  • Abbreviated Approval Process for Biosimilars Survives in Supreme...
    among the justices, the high court upheld the Biologics Price Competition and Innovation (BPCI) Act of 2009, incorporated within Obama's Patient Protection and Affordable Care Act. ...
    6-28-2012
  • FDA Releases Biosimilars Guidelines to Little Fanfare
    ... The Patient Protection and Affordable Care Act, signed into law by President Barack Obama on March 23, 2010, mandated the creation of an abbreviated approval pathway for ...
    3-15-2012
  • What Will FDA Biosimilars Guidelines Mean for Industry?
    ... The Patient Protection and Affordable Care Act, signed into law by President Barack Obama on March 23, 2010, mandated the creation of an abbreviated approval pathway for ...
    2-16-2012
  • FDA Issues Draft Guidance for Getting Biosimilars Approved
    reference product and was part of President Barack Obama's Patient Protection and Affordable Care Act. "[The draft guidances] should help biosimilar developers understand ...
    2-9-2012
  • NIH Spending Barely Budges, CDC Stays Flat as Congress Finalizes...
    ... $100 million initially proposed by NIH for CAN. CAN was authorized by the Patient Protection and Affordable Care Act enacted by President Obama last year but not funded until now. ...
    12-19-2011
  • FDA Holds Public Discussion of User Fee Program for Biosimilars
    Price Competition and Innovation Act (BPCIA) of 2009. BPCIA was tucked into page 686 of the Patient Protection and Affordable Care Act enacted last year by President Obama. ...
    12-15-2011
  • Driving Down Medical and Healthcare Spending
    Ph.D. Two basic premises behind the Affordable Care Act, which was signed into law last year by ... Over time, when patent protection expires, the resulting generics and biosimilars ...
    10-15-2011

  • Journal Articles

  • What's in a Name Anyway?
    Stephanie Lacefield Lewis
    Journal of Palliative Medicine
    The Patient Protection and Affordable Care Act in its first drafts contained clauses to provide ways in which to reach these goals. Due to a lack of public knowledge about ...
  • Complementary and Alternative Medicine Practitioners and Accountable...
    Matthew A. Davis, James M. Whedon, William B. Weeks
    Journal of Alternative and Complementary Medicine, The
    recently enacted into law as part of the Patient Protection and Affordable Care Act, and in 2012 the Centers for Medicare and Medicaid Services will begin contracting with ACOs. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll